3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Neoplasm Metastasis
2
Sarcoma, Synovial
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Tumors
1
Mouth Neoplasms
1
Lymphatic Metastasis
1
Liposarcoma
1
Leukemia, Myeloid, Acute
1
Leiomyosarcoma
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Histiocytoma, Malignant Fibrous
1
Gliosarcoma
1
Glioblastoma
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Dermatofibrosarcoma
1
Cholangiocarcinoma
1
Carcinoma
1
Interventions
pembrolizumab
4
Proton Therapy
3
toripalimab
1
spartalizumab
1
patritumab deruxtecan
1
osimertinib
1
mirdametinib
1
leronlimab
1
amivantamab
1
Valganciclovir
1
Radiotherapy
1
Paclitaxel
1
Lacteol
1
Interleukin-2
1
Docetaxel
1
Carboplatin
1
Blood Specimen Collection
1
Bevacizumab
1
BGB-283
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor, Adult
×
peposertib
×
1 year
×
Clear all
No trials found.